A systematic overview of rare disease patient registries: challenges in design, quality management, and maintenance
- PMID: 37147718
- PMCID: PMC10163740
- DOI: 10.1186/s13023-023-02719-0
A systematic overview of rare disease patient registries: challenges in design, quality management, and maintenance
Abstract
Patient registries serve to overcome the research limitations inherent in the study of rare diseases, where patient numbers are typically small. Despite the value of real-world data collected through registries, adequate design and maintenance are integral to data quality. We aimed to describe an overview of the challenges in design, quality management, and maintenance of rare disease registries.A systematic search of English articles was conducted in PubMed, Ovid Medline/Embase, and Cochrane Library. Search terms included "rare diseases, patient registries, common data elements, quality, hospital information systems, and datasets". Inclusion criteria were any manuscript type focused upon rare disease patient registries describing design, quality monitoring or maintenance. Biobanks and drug surveillances were excluded.A total of 37 articles, published between 2001 and 2021, met the inclusion criteria. Patient registries covered a wide range of disease areas and covered multiple geographical locations, with a predisposition for Europe. Most articles were methodological reports and described the design and setup of a registry. Most registries recruited clinical patients (92%) with informed consent (81%) and protected the collected data (76%). Whilst the majority (57%) collected patient-reported outcome measures, only few (38%) consulted PAGs during the registry design process. Few reports described details regarding quality management (51%) and maintenance (46%).Rare disease patient registries are valuable for research and evaluation of clinical care, and an increasing number have emerged. However, registries need to be continuously evaluated for data quality and long-term sustainability to remain relevant for future use.
Keywords: Data quality; Design; Maintenance; Patient registry; Rare disease.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Impact of biobanks on research outcomes in rare diseases: a systematic review.Orphanet J Rare Dis. 2018 Nov 12;13(1):202. doi: 10.1186/s13023-018-0942-z. Orphanet J Rare Dis. 2018. PMID: 30419920 Free PMC article.
-
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881. Med J Aust. 2020. PMID: 33314144
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
A Quality Assessment of the ARM-Net Registry Design and Data Collection.J Pediatr Surg. 2023 Oct;58(10):1921-1928. doi: 10.1016/j.jpedsurg.2023.02.049. Epub 2023 Feb 25. J Pediatr Surg. 2023. PMID: 37045715
-
Current state of rare disease registries and databases in Australia: a scoping review.Orphanet J Rare Dis. 2023 Jul 27;18(1):216. doi: 10.1186/s13023-023-02823-1. Orphanet J Rare Dis. 2023. PMID: 37501152 Free PMC article.
Cited by
-
Emery-Dreifuss muscular dystrophy: a closer look at cardiac complications.Eur Heart J. 2023 Dec 21;44(48):5074-5076. doi: 10.1093/eurheartj/ehad735. Eur Heart J. 2023. PMID: 37941127 Free PMC article. No abstract available.
-
How to customize common data models for rare diseases: an OMOP-based implementation and lessons learned.Orphanet J Rare Dis. 2024 Aug 14;19(1):298. doi: 10.1186/s13023-024-03312-9. Orphanet J Rare Dis. 2024. PMID: 39143600 Free PMC article.
-
Drug Repurposing and Lysosomal Storage Disorders: A Trick to Treat.Genes (Basel). 2024 Feb 25;15(3):290. doi: 10.3390/genes15030290. Genes (Basel). 2024. PMID: 38540351 Free PMC article. Review.
-
Ethical, Legal, and Social Assessment of AI-Based Technologies for Prevention and Diagnosis of Rare Diseases in Health Technology Assessment Processes.Healthcare (Basel). 2025 Apr 4;13(7):829. doi: 10.3390/healthcare13070829. Healthcare (Basel). 2025. PMID: 40218125 Free PMC article.
-
Health-related quality of life and associated risk factors in patients with Multiple Osteochondromas: a cross-sectional study.Qual Life Res. 2024 May;33(5):1323-1334. doi: 10.1007/s11136-024-03604-4. Epub 2024 Mar 8. Qual Life Res. 2024. PMID: 38457053 Free PMC article.
References
-
- Gliklich RE, Leavy MB, Dreyer NA. Registries for Evaluating Patient Outcomes: A User’s Guide. Rockville, MD, United States: Agency for Healthcare Research and Quality (US) September 2020. Report No.: 19(20)-EHC020. - PubMed
-
- Orphanet. Rare Disease Registries in Europe. 2021. Available from: http://www.orpha.net/orphacom/cahiers/docs/GB/Registries.pdf.
-
- European Union Committee of Experts on Rare Diseases: Recommendations on European Reference Networks for rare diseases, European Union Committee of Experts on Rare Diseases; 2013. Available from: https://health.ec.europa.eu/publications/eucerd-core-recommendations-rar....
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous